St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Research
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Research homes in on drug to dampen inflammation fueling life-threatening immune disorder
Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.
Separating fact from fiction using pharmacogenetics
Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.
Chaperones: probing the structural secrets of the cell’s front-line protein protectors
Read how this protein, called a chaperone, does more than simply monitor the intracellular dance of protein folding – it protects them from going awry.
Rare childhood disorders widen window on diseases of aging
Read how extremely rare genetic childhood diseases offer clues about understanding neurodegenerative disorders common with aging.
PeCanPIE offers powerful tools for discovering inherited cancer genes
Powerful cancer data portal gets an upgrade to identify the genetic culprit for inherited cancer and possibly other genetic diseases.
Pediatric immunotherapy: How two immunologists are paving the way for improved treatments
Two friends and research colleagues are looking at different stages of the immune response to pave the way for enhanced cancer treatments.
Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?
High science calls on Star Wars character as a potential ally against Alzheimer’s disease.
SJELIOT clinical trial explores a new approach for recurring and unresponsive medulloblastoma tumors
St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.
Acute lymphoblastic leukemia: collaborations in China showcase the power of global cancer care
An agreement between one U.S. hospital and two Chinese hospitals in 1991 has completely changed global pediatric cancer care.
Optimizing leukemia treatment through pharmaceutical science
Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.